Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Chemoreceptor Control of Breathing During Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing

NCT05589753 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT05589753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05589753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Chemoreceptor Control of Breathing During Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing
Lead sponsor
VA Office of Research and Development
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 2, 2019
Completion date
March 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use, sleep apnea, sleep disordered breathing